Using the 0.2 IU/ml cut-off, no significant difference in CMV infection-free survival at M12 was observed between patients with a reactive and a non-reactive QF-Ag at M1 (76.7% [95% CI: 60.8; 86.8] versus 69.2% [95% CI: 37.3; 87.1], respectively, plog-rank = 0.6014) (Figure 7A). Here, RENBP is linked to cytomegalovirus infection.